financetom
Business
financetom
/
Business
/
--Rio Tinto Said to Nix Plans for Up to $5 Billion Share Sale, Bloomberg Reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Rio Tinto Said to Nix Plans for Up to $5 Billion Share Sale, Bloomberg Reports
Mar 7, 2025 11:07 AM

01:58 PM EST, 03/07/2025 (MT Newswires) --

Price: 62.60, Change: +0.91, Percent Change: +1.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cinema operator Reading International Q3 revenue drops 13%
Cinema operator Reading International Q3 revenue drops 13%
Nov 14, 2025
Overview * Reading International Q3 2025 revenue decreased 13% * Company reported best quarterly results since 2019, Q3 net loss improved by 41% yr/yr * Company reduced debt by almost 15% through real estate asset sales Outlook * Company expects fourth-quarter cinema rebound with promising holiday film lineup * Reading anticipates strong 2026 movie release schedule * Company highlights strong...
Gladstone Investment to Redeem $74.8 Million in 2028 Notes
Gladstone Investment to Redeem $74.8 Million in 2028 Notes
Nov 14, 2025
09:12 AM EST, 11/14/2025 (MT Newswires) -- Gladstone Investment ( GAIN ) said Friday it will redeem on Dec. 16 all $74.8 million of its 8.00% notes due 2028. The company said noteholders will receive the full principal amount along with accrued and unpaid interest through the redemption date. The 2028 notes will be delisted from the Nasdaq Global Select...
Avadel Pharmaceuticals Receives Unsolicited Acquisition Proposal From Lundbeck
Avadel Pharmaceuticals Receives Unsolicited Acquisition Proposal From Lundbeck
Nov 14, 2025
09:12 AM EST, 11/14/2025 (MT Newswires) -- Avadel Pharmaceuticals ( AVDL ) said Friday that it received an unsolicited acquisition proposal from Lundbeck for up to $23 per share, which would reasonably be expected to result in a Company Superior Proposal under its existing agreement with Alkermes ( ALKS ) . The company previously agreed to be acquired by Alkermes...
Forte Biosciences Q3 net loss per share improves
Forte Biosciences Q3 net loss per share improves
Nov 14, 2025
Overview * Forte Biosciences Q3 2025 net loss per share decreased compared to the same period in 2024 * Research and development expenses rose due to increased clinical trial activities * Company expects three clinical trial readouts for FB102 in 2026 Outlook * Forte expects three clinical trial readouts for FB102 in 2026 * Company anticipates topline data for celiac...
Copyright 2023-2026 - www.financetom.com All Rights Reserved